Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
/in Breast Cancer, Dendritic Cells, International Publications /von 2007-02-09 / Cancer Res 2007 Feb;67(4):1842-52Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
/in Breast Cancer, Dendritic Cells, International Publications /von 2007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-99Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
/in Breast Cancer, International Publications /von 2007-01-03 / Vaccine 2007 Mar;25(14):2610-9[Induction of specific CTL by DC from axillary lymph node of patients with breast cancer]
/in Breast Cancer, International Publications /von 2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-2Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
/in Breast Cancer, International Publications, Malignant Melanoma /von 2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-30Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-86[Clinical impact of locoregional hyperthermia in gynecological oncology]
/in Breast Cancer, Cervical Cancer, Hyperthermia, International Publications /von 2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-60Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer
/in Breast Cancer, International Publications /von 2006-08-01 / Mol. Cancer Ther. 2006 Aug;5(8):1975-85Dendritic cell immunotherapy for breast cancer
/in Breast Cancer, International Publications /von 2006-06-01 / Expert Opin Biol Ther 2006 Jun;6(6):591-604
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de